An observational study in Inflammatory Bowel Disease, sponsored by Scientific Center of Children's Health RAMS. Completed at 1 site in Russian Federation. Open to participants aged 10 Years to 21 Years. Per ClinicalTrials.gov, last updated 2014-11-19.
Sponsored by Scientific Center of Children's Health RAMS · Observational
Studies over the past two decades have convincingly demonstrated the role of barrier dysfunction in the pathogenesis of inflammatory bowel disease. It previously shown that optical biopsy with probe-based confocal laser endomicroscopy (pCLE) could be used to assess mucosal barrier function. Furthermore, mucosal barrier dysfunction on pCLE was shown to be predictive of disease relapse in adult IBD patients. The purpose of the current study is to determine the predictive value of pCLE findings in pediatric IBD patients.
1,460 studies on the registry are indexed under Inflammatory Bowel Diseases; 437 are open to participants now.
This study's enrollment of 24 is below the median of 139 across 645 observational studies indexed under Inflammatory Bowel Diseases.
Browse Inflammatory Bowel Diseases studies →This is the only study on the registry with Scientific Center of Children's Health RAMS as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Pediatric patients with IBD from all over Russia, treated from IBD in our Center
Exclusion Criteria:
Primary study end-point was moderate to severe flare requiring hospitalization after pCLE
The purpose of the current study is to determine the predictive value of pCLE findings in pediatric IBD patients.
Time frame: follow up period was a median of 18 months (range 4 to 33)
This study is completed, as verified in Nov 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.